Skip to main content
OpenTrials
Completed

NCT Number: NCT01386138

Treating South African Pregnant Women for Methamphetamine

The purpose of this study was to develop and initially evaluate an efficacious, comprehensive, culturally sensitive, women-centered model of care for pregnant South African women by adapting and refining PI Jones' Reinforcement-Based Treatment (RBT) model, at the same time integrating into it the HIV prevention components of Co-I Wechsberg's Women's Health CoOp (WHC) model, yielding an integrated treatment and prevention model, RBT+WHC.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Medical Research Council

Tygerberg, Western Cape, 7505, South Africa

About this study

Cape Town is a striking example of the need for women-specific substance abuse treatment, as it is experiencing a devastating level of methamphetamine use (7% of the adult population),especially among women of childbearing age. The use of methamphetamine (hereafter referred to as "meth") is higher in Cape Town than anywhere else in the country. Consequently, there has been a critical need to develop and test a woman-focused intervention that reduces meth use in a highly vulnerable population of South African women.

Since 2001, the Women's Health CoOp (WHC; PI Wechsberg; RO1s DA011609S; AA014488; HD058320) has successfully adapted an evidence-based intervention to reduce sex- and drug-risk behaviors in drug-using South African women. However, with a rapid rise in meth use, the Western Cape is experiencing a new drug epidemic. A previous WHC study data indicated that the WHC had limited success in reducing the use of this among women. Alarmingly, among WHC participants, a greater proportion of pregnant than non-pregnant women reported using meth (n=24/26=92%; n=238/356=67%; p=.01). These findings are underscored by a lack of a focused and intensive treatment for meth-using pregnant women who live in impoverished townships. Thus, this project responded to PA-09-021 International Research Collaboration on Drug Abuse and Addiction Research (R21) by developing treatment options for meth use among pregnant women and using the long collaboration between WHC staff and local treatment providers to develop our first project to treat meth use in pregnant women.

The goal of this project was to develop and initially evaluate an efficacious, comprehensive, culturally sensitive, women-centred model of care for pregnant South African women by adapting and refining PI Jones' Reinforcement-Based Treatment (RBT) model, at the same time integrating into it the HIV prevention components of Co-I Wechsberg's Women's Health CoOp (WHC) model, yielding an integrated treatment and prevention model, RBT+WHC.

The study had two sequential aims: Aim 1: Adapt and pretest a comprehensive drug abuse treatment model, RBT, which integrated the evidence-based WHC HIV prevention model, to produce a comprehensive, culturally sensitive, woman-focused intervention for meth-using pregnant Coloured women, RBT+WHC. Aim 2: Conduct a small-scale randomized controlled trial (RCT) with pregnant Coloured women to determine the acceptability, feasibility, and initial efficacy of the RBT+WHC model relative to a psycho-educational control condition in terms of their respective impact on maternal outcomes, including (a) meth use, (b) frequency of unprotected sex acts, and (c) number of prenatal care visits; and neonatal outcomes including (d) length of hospital stay, (e) birth weight, and (f) gestational age at delivery. About 300 women were screened for the study but only 32 were found to eligible and completed the study.

The public health impact of this project was far-reaching. RBT+WHC aimed to fill a critical gap in substance use treatment research in a social structure where women are disproportionately disenfranchised from receiving healthcare compared with men. Furthermore, this initial study laid the foundation for a full-scale RCT to examine the impact of RBT+WHC on an array of maternal and neonatal outcomes, within the population of pregnant Coloured as well as Black and White South African women.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • are 18 years of age or older
  • self-identify as "Coloured" (this is a cultural grouping of people with mixed-race ancestry)
  • live in the Cape Town township communities of Mitchell's Plain, Delft, Elsie's River, Belhar, Bishop Lavis, or Ravensmead
  • meet current DSM-IV criteria for methamphetamine abuse or dependence
  • are willing to enter drug abuse treatment
  • report unprotected sex in the past 30 days
  • are HIV negative
  • provide verifiable locator information for follow-up interview
  • are 20-28 weeks pregnant, inclusive, and determined by last menstrual period

Exclusion criteria

  • are male
  • are younger than 18 years
  • do not self-identify as "Coloured"
  • do not live in the Cape Town township communities of Mitchell's Plain, Delft, Elsie's River, Belhar, Bishop Lavis, or Ravensmead
  • do not meet current DSM-IV criteria for methamphetamine abuse or dependence
  • are not willing to enter drug abuse treatment
  • have not reported unprotected sex in the past 30 days
  • are HIV positive
  • do not provide verifiable locator information for follow-up interview
  • are not 20-28 weeks pregnant
  • are not able to provide informed consent

Treatment and study plan

Psycho-education

Behavioral

Receive RBT education and peer-support in a group format.

Experimental

Behavioral

Receive RBT education and a pro-active counseling method

Primary outcomes

  1. Methamphetamine practices

    Time frame: 3 months after randomization

    Frequency of methamphetamine use in past 30 days measured by RRBA (WHC Revised Risk Behavior Assessment) and urine test

  2. Prenatal care

    Time frame: At time of delivery

    Number of prenatal care visits measured by chart review of hospital record

  3. Length of hospital stay

    Time frame: At time of delivery

    Length of hospital stay measured by chart review of hospital record

Secondary outcomes

  1. Drug Use

    Time frame: 3 months after randomization

    Frequency of opioid, cocaine, mandrax, marijuana, and self-report nicotine use in past 30 days measured by RRBA (WHC Revised Risk Behavior Assessment) and urine test

  2. Drug and alcohol use composite scores

    Time frame: 3 months after randomization

    Drug and alcohol composite scores measured by the Addiction Severity Index

  3. Alcohol use

    Time frame: 3 months after randomization

    Frequency of alcohol use in past 30 days measured by RRBA and breath test

  4. Sexual practices

    Time frame: 3 months after randomization

    Frequency of unprotected sexual acts at last sexual encounter and in past 30 days measured by RRBA

  5. Birthweight

    Time frame: At time of delivery

    Birthweight measured by chart review of hospital record

  6. Estimated gestational age

    Time frame: At time of delivery

    Estimated gestational age measured by chart review of hospital record

Sponsors and collaborators

Lead sponsor

RTI International

Other

Collaborators

  • University of Cape Town

Registry information

Important dates

Study start
2011
Primary completion
2013
Study completion
2013
First posted
Jun 30, 2011
Registry last updated
Jan 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.